RecruitingPhase 4NCT07487077

Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya

Studying Cholera

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Albert B. Sabin Vaccine Institute
Intervention
Euvichol-S Oral Cholera Vaccine(drug)
Enrollment
1071 enrolled
Eligibility
1 years · All sexes
Timeline
20252028

Study locations (1)

Collaborators

Kenya Medical Research Institute · Washington State University · Massachusetts General Hospital · Kenya Ministry of Health · Nairobi City County

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07487077 on ClinicalTrials.gov

Other trials for Cholera

Additional recruiting or active studies for the same condition.

See all trials for Cholera

← Back to all trials